The Company:
With deep expertise in chemistry, Nuvalent is working to create selective medicines designed with the goal to address the needs of patients with cancer. Nuvalent is an exciting early-stage company, bringing together experienced scientists and industry veterans with a proven track record in drug discovery, oncology drug development, and company building.
The Role:
Reporting to the Vice President of Financial Planning & Analysis (FP&A), the Director, Financial Planning & Analysis (FP&A) will play a pivotal role in Nuvalent’s continued growth. The Director, FP&A will be a hands-on key contributor to the financial planning and reporting process at Nuvalent.
Working closely with key stakeholders, this is a highly visible role that will primarily be responsible for elevating our manufacturing finance & cost accounting capabilities as we prepare for our commercial launch & post launch stage. This role will strive to provide effective financial forecasting, reporting and analysis of operating results to enable sound business decisions. The ideal candidate is a result oriented, self-starter who is looking to join a rapidly growing company.
Responsibilities:
• Partner closely with Finance/Accounting, Technical Operations & Commercial teams with commercial manufacturing & supply chain related activities including COGS modeling, inventory workflow, CMOs & 3PLs contracting & financial management
• Drive budgeting, forecasting, and planning initiatives, including monthly, quarterly, and annual financial reporting packages and budget to actual analysis for the assigned business areas
• Represent the FP&A team on the Launch Readiness Team (LRT) & S&OP processes; supporting the initiatives required for a successful launch & post-launch activities of our multi-product portfolio
• Manage standard costing for peri-commercial & commercial products, and understand and analyze variances and margins to provide meaningful information for decision-making
• Develop a process to capture, track, record, and report costs when commercial manufactured products / inventory locations / business collaborations / contract manufacturing organizations are added or changed
• Champion system implementation and enhancements in coordination with Technical Operations, IT, and Accounting, as needed, to ensure flow of information for models & reporting is timely, accurate and reliable for internal and external consumption
• Support Supply Chain team with physical inventory process & report results to drive action
• Strong collaboration with accounting & business teams for the monthly close process & timelines while adhering to internal controls
• Provide input to presentations for the leadership team and the board of directors
• Ad-hoc financial projects & initiatives as assigned
Competencies:
• Strong interpersonal skills to collaborate, influence and build credibility with business partners across the organization & especially with Accounting, Technical Operations & Commercial teams
• Passion for designing, implementing & streamlining systems, processes & reporting, with attention to detail & accuracy
• Thrive with constant change & continuous improvement, "rolling up sleeves", performing in a fast-paced, dynamic work environment
• Strong analytical skills coupled with the ability to make recommendations for changes as needed
• High level of integrity and principles that embrace transparency and ethics
• Results orientated work ethic and a positive, can-do attitude
Qualifications:
• Bachelor’s degree in Finance, Accounting or relevant degree, MBA preferred
• 10-12 years of progressive financial reporting, planning and analysis experience in the pharmaceutical or biotechnology industry
• Prior experience transitioning an organization to Commercial launch, specifically as it relates to manufacturing & supply chain is highly preferred
• System savvy, ideally with experience implementing or overseeing financial planning and reporting tools. Experience with NetSuite & IBM Planning Analytics is a plus
• Strong communications skills and executive presence
• Excellent Excel, PowerPoint, and analytical skills
Nuvalent provides equal employment opportunities (EEO) to all employees and applicants for employment without regard to religion, race, creed, color, sex, sexual orientation, alienage or citizenship status, national origin, age, marital status, pregnancy, disability, veteran or military status, predisposing genetic characteristics or any other characteristic protected by applicable federal, state or local law.
Nuvalent is aware that many companies are dealing with fraudulent job postings on third-party employment search sites and/or individual(s) or entities claiming to be employees of such companies. Those involved are offering fraudulent employment opportunities to applicants, often asking for sensitive personal and financial information, and using such information for criminal activities.
Please be advised that all legitimate correspondence from a Nuvalent employee will come from "@nuvalent.com" email accounts. Automated system response emails from our Greenhouse applicant tracking system come from a “[email protected]” email address. There are no variations of these email addresses and Nuvalent would not request personal and/or financial information via email. Job opportunities would only be extended after a completed job application is submitted by a candidate and a thorough interview process including 1:1 and/or group interviews via phone, video conferencing and/or in-person.
If you believe you have been contacted by anyone misrepresenting themselves as an employee of Nuvalent, please contact Nuvalent at 857-357-7000. Thank you.
Top Skills
What We Do
Nuvalent is creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in structure-based design, Nuvalent develops innovative small molecules with exquisite target selectivity to overcome resistance, minimize adverse events, and drive more durable responses. Nuvalent is advancing a robust pipeline with parallel lead programs in ROS1-positive and ALK-positive NSCLC, along with multiple discovery-stage research programs. To learn more, visit www.nuvalent.com.
.png)
